血管生成素-2与急性呼吸窘迫综合征患者预后的相关性研究
该回顾性研究纳入浙江省同德医院急诊医学科2020年12月至2022年9月收治的132例ARDS患者,记录治疗前及治疗后24、48、72小时血浆Ang-2水平及60天预后。49例60天内死亡,83例存活;死亡组血浆Ang-2呈逐渐升高趋势,各时间点均显著高于治疗前,且治疗后24、48、72小时均显著高于存活组。校正混杂因素后,血浆Ang-2升高是ARDS患者60天预后的独立危险因素(OR=0.998,95%CI 0.997-0.999,P<0.01);ROC曲线AUC=0.985(95%CI 0.971-1.000),最佳截断值8.43 μg/L,约登指数0.867。Pearson相关分析显示Ang-2与PVPI、EVLWI正相关(r分别为0.620和0.712,均P<0.01)。
要点
- 132例ARDS患者中49例60天内死亡、83例存活;死亡组治疗后24、48、72小时血浆Ang-2均显著高于存活组(均P<0.05)。
- 死亡组血浆Ang-2呈逐渐升高趋势,24、48、72小时均显著高于治疗前(μg/L:12.75±1.81、12.74±1.48、13.45±2.21 vs. 5.98±0.57,均P<0.05),存活组趋势不显著。
- 校正混杂因素后,血浆Ang-2升高是ARDS患者60天预后的独立危险因素(OR=0.998,95%CI 0.997-0.999,P<0.01)。
- Ang-2预测ARDS预后的AUC=0.985(95%CI 0.971-1.000),最佳截断值8.43 μg/L,约登指数0.867。
- 血浆Ang-2与PVPI、EVLWI呈正相关(r分别为0.620和0.712,均P<0.01)。
适用人群与场景
- 浙江省同德医院急诊医学科2020年12月至2022年9月收治的ARDS患者,共132例,其中60天内死亡49例、存活83例。
诊断标准与关键阈值
- Ang-2预测ARDS患者60天预后的ROC曲线最佳截断值为8.43 μg/L,约登指数0.867,AUC=0.985(95%CI 0.971-1.000)。
研究设计与关键结果
- 研究类型为回顾性研究,纳入132例ARDS患者,记录性别、年龄、ARDS病因、疾病严重程度评分、治疗前及治疗后24、48、72小时血浆Ang-2水平及60天预后。
- 死亡组血浆Ang-2呈逐渐升高趋势,24、48、72小时均显著高于治疗前(μg/L:12.75±1.81、12.74±1.48、13.45±2.21 vs. 5.98±0.57,均P<0.05);存活组趋势不显著。
- 治疗后24、48、72小时死亡组血浆Ang-2均显著高于存活组(μg/L:12.75±1.81 vs. 7.48±1.22,12.74±1.48 vs. 7.41±1.19,13.45±1.41 vs. 6.88±1.41,均P<0.05)。
- 校正混杂因素后,血浆Ang-2升高是ARDS患者60天预后的独立危险因素(OR=0.998,95%CI 0.997-0.999,P<0.01)。
- ROC曲线分析显示Ang-2对ARDS预后有预测价值(AUC=0.985,95%CI 0.971-1.000,约登指数0.867,最佳截断值8.43 μg/L)。
- Pearson相关分析显示血浆Ang-2与PVPI、EVLWI呈正相关(r分别为0.620和0.712,均P<0.01)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,Ang-2水平升高是ARDS患者死亡率增加的独立危险因素,治疗后72小时内Ang-2水平较高可能提示预后较差。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the predictive value of angiopoietin-2 (Ang-2) for the prognosis in patients with acute respiratory distress syndrome (ARDS).
METHODS: A retrospective study was conducted, and ARDS patients admitted to the department of emergency medicine of Tongde Hospital of Zhejiang Province from December 2020 to September 2022 were enrolled. General information including gender, age, causes of ARDS, disease severity scores, plasma Ang-2 levels before treatment and at 24, 48, and 72 hours after treatment, and record the 60-day prognosis were collected. Differences in clinical data between groups were compared. Multivariate Logistic regression analysis was used to identify the independent risk factors affecting the 60-day prognosis of ARDS patients, and the receiver operator characteristic curve (ROC curve) was plotted to assess the predictive value of these risk factors for patient outcomes. Pearson correlation analysis was used to assess the correlation between Ang-2 and pulmonary vascular permeability index (PVPI) and extravascular lung water index (EVLWI).
RESULTS: A total of 132 ARDS patients were included, of which 49 patients died within 60 days and 83 patients survived. In the death group, plasma Ang-2 levels showed a gradually increasing trend, all significantly higher than before treatment (μg/L: 12.75±1.81, 12.74±1.48, 13.45±2.21 vs. 5.98±0.57, all P < 0.05), while the trend in the survival group was not significant. At 24, 48, and 72 hours after treatment, plasma Ang-2 levels in the death group were significantly higher than those in the survival group (μg/L: 12.75±1.81 vs. 7.48±1.22, 12.74±1.48 vs. 7.41±1.19, 13.45±1.41 vs. 6.88±1.41, all P < 0.05). After adjusting for confounding variables, increased plasma Ang-2 level was an independent risk factor for prognosis in ARDS patients within 60 days [odds ratio (OR) = 0.998, 95% confidence interval (95%CI) was 0.997-0.999, P < 0.01]. ROC curve analysis demonstrated that Ang-2 levels had predictive value for prognosis in ARDS patients [area under the ROC curve (AUC) = 0.985, 95%CI was 0.971-1.000, approximate maximum Youden's index 0.867, optimal cut-off value 8.43 μg/L]. Pearson correlation analysis showed that plasma Ang-2 levels were positively correlated with PVPI and EVLWI ( r values were 0.620 and 0.712 respectively, both P < 0.01).
CONCLUSIONS: Elevated level of Ang-2 is an independent risk factor for increased mortality in patients with ARDS. Higher Ang-2 levels within 72 hours after treatment may indicate poorer prognosis.
参考来源
- Zhang L, Bai X, Li Y, et al. [Study on the correlation between angiopoietin-2 and prognosis in patients with acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39380518. doi:10.3760/cma.j.cn121430-20240314-00235
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。